Home > Boards > US OTC > Medical - Drugs > Tenax Therapeutics, Inc. (TENX)

We will see who gets the last laugh,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
makingbiigdough Member Profile
 
Followed By 120
Posts 4,746
Boards Moderated 1
Alias Born 10/20/01
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/27/2020 6:01:11 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/23/2020 5:04:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/13/2020 8:17:06 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/13/2020 8:09:05 AM
Tenax Therapeutics Completes Enrollment in Phase 2 Pulmonary Hypertension Trial Business Wire - 3/12/2020 8:30:00 AM
Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market Business Wire - 3/12/2020 8:00:00 AM
Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board Business Wire - 2/21/2020 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 10:26:46 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 1:53:21 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/7/2020 8:48:44 AM
Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial Business Wire - 1/13/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2020 8:08:04 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:34:57 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 11/8/2019 5:01:34 PM
Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial Business Wire - 10/31/2019 8:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/30/2019 4:34:52 PM
Tenax Therapeutics to Present at H.C. Wainwright 21st Annual Global Investment Conference Business Wire - 8/29/2019 8:00:00 AM
Tenax Therapeutics Provides Clinical Development Update Business Wire - 8/23/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:33:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 4:34:25 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:54:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2019 4:31:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/19/2019 4:32:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:34:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:34:00 PM
makingbiigdough   Friday, 09/20/19 03:34:45 PM
Re: casenumber post# 7956
Post # of 8039 
We will see who gets the last laugh, when I cash in 7++ figures either before approval on news, or after. Also you need to learn how to read better. #7936!! MBD

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist